Drugs Made In America Acquisiti (DMII): Valuation
TTM figures as of June 30, 2026
Drugs Made In America Acquisiti trades at 51.2 times trailing earnings. The Financial Services median P/E is 14.5.
Earnings yield 1.95%. Net debt $725.0K.
9 month-end valuation observations are on file, starting December 2025.
Sector comparison uses 3659 Financial Services names.
Frequently asked questions
Is DMII cheap versus its own history?
Drugs Made In America Acquisiti trades at 51.2 times trailing earnings. The Financial Services median P/E is 14.5.
What is DMII's free-cash-flow yield?
Free-cash-flow yield is trailing free cash flow divided by the live market cap. It is omitted when free cash flow is missing.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.